Arcadia Biosciences, Inc. (RKDA)

Arcadia Biosciences, Inc. (RKDA) Materials & Commodity Exposure

Arcadia Biosciences, Inc. develops and markets plant-based health and wellness products, primarily focused on crop improvement in wheat. The company aims to enhance farm economics and the value of crops as food ingredients and industrial applications, operating within the agricultural inputs sector.

What Is the Investment Thesis for RKDA?

Arcadia Biosciences presents a speculative investment opportunity within the agricultural biotechnology sector. The company's focus on crop improvement, particularly in wheat, addresses the growing demand for sustainable and nutritious food sources. However, with a market capitalization of $1.15M and negative profitability (P/E of -0.47 and Profit Margin of -98.0%), the company faces significant financial challenges. Key value drivers include successful commercialization of its improved crop varieties and strategic partnerships. Upcoming catalysts include potential regulatory approvals for its products and expansion into new markets. Potential risks include competition from larger agricultural companies, regulatory hurdles, and the need for additional funding to support ongoing operations.

Based on FMP financials and quantitative analysis

RKDA Key Highlights

• Market Cap of $1.15M indicates a micro-cap company with high growth potential but also significant risk.
• Negative P/E ratio of -0.47 reflects the company's current lack of profitability.
• Profit Margin of -98.0% highlights the significant challenges in achieving profitability.
• Gross Margin of 37.8% suggests potential for profitability if operating expenses are managed effectively.
• Beta of 0.61 indicates lower volatility compared to the overall market.

Who Are RKDA's Competitors?

RKDA is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.

AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance

What Are RKDA's Key Strengths?

• Proprietary crop technologies.
• Focus on specific crop traits and market needs.
• Expertise in agricultural biotechnology.
• Potential for sustainable and high-yield crop varieties.

What Are RKDA's Weaknesses?

• Negative profitability and high operating expenses.
• Limited market share and brand recognition.
• Reliance on regulatory approvals and government incentives.
• Small number of employees.

What Could Drive RKDA Stock Higher?

• Potential regulatory approvals for new crop varieties.
• Expansion into new geographic markets.
• Strategic partnerships and collaborations.
• Development of new crop traits and products.

What Are the Key Risks for RKDA?

• Weak fundamentals — a Piotroski F-Score of 2/9 flags soft profitability, leverage or efficiency.
• Competition from larger agricultural companies.
• Regulatory hurdles and changing government policies.
• Negative profitability and high operating expenses.
• Fluctuations in commodity prices and market demand.

What Are the Growth Opportunities for RKDA?

• Expansion into international markets: Arcadia Biosciences has the opportunity to expand its market reach beyond the United States by targeting key international markets with a high demand for improved crop varieties. This expansion could significantly increase revenue and market share, leveraging the company's proprietary technologies and crop improvements. The global market for agricultural inputs is projected to reach $300 billion by 2028, providing a substantial opportunity for growth.
• Development of new crop traits: Arcadia Biosciences can invest in research and development to create new crop traits that address specific market needs, such as increased drought tolerance or enhanced nutritional content. This would allow the company to differentiate its products and capture a larger share of the market. The market for genetically modified crops is expected to grow at a CAGR of 7% over the next five years.
• Strategic partnerships and collaborations: Arcadia Biosciences can form strategic partnerships with other companies in the agricultural sector to leverage their expertise and resources. This could include collaborations with seed companies, food processors, or agricultural technology providers. Such partnerships can accelerate the commercialization of Arcadia's products and expand its market reach. Alliances can be formed within the next 1-2 years.
• Increased focus on sustainable agriculture: With growing concerns about climate change and environmental sustainability, Arcadia Biosciences can capitalize on the demand for sustainable agricultural practices by developing crop varieties that require less water, fertilizer, or pesticides. This would appeal to environmentally conscious farmers and consumers and enhance the company's brand image. Sustainable agriculture is projected to be a $15 billion market by 2027.
• Leveraging government incentives and subsidies: Arcadia Biosciences can take advantage of government incentives and subsidies that support agricultural research and development. This could include grants, tax credits, or other forms of financial assistance. By securing government funding, Arcadia can reduce its financial burden and accelerate the development of new crop technologies. These incentives are ongoing and can be leveraged immediately.

What Opportunities Does RKDA Have?

• Expansion into international markets.
• Development of new crop traits and products.
• Strategic partnerships and collaborations.
• Increased focus on sustainable agriculture.

What Threats Does RKDA Face?

• Competition from larger agricultural companies.
• Regulatory hurdles and changing government policies.
• Fluctuations in commodity prices and market demand.
• Potential for technological obsolescence.

What Are RKDA's Competitive Advantages?

• Proprietary crop technologies and intellectual property.
• Focus on specific crop traits and market needs.
• Strategic partnerships and collaborations.
• Expertise in agricultural biotechnology and crop improvement.

What Does RKDA Do?

Arcadia Biosciences, Inc., founded in 2002 and headquartered in Davis, California, is an agricultural biotechnology company focused on enhancing the value and sustainability of crops. The company develops and markets plant-based health and wellness products in the United States. Arcadia's primary focus is on crop improvement, particularly in wheat, to enhance farm economics by improving crop performance in the field. These improvements also increase the value of crops as food ingredients, health and wellness products, and for industrial applications. Arcadia utilizes advanced breeding techniques and genetic engineering to develop crops with improved traits such as enhanced nutritional content, improved yield, and increased tolerance to environmental stresses. The company's products are designed to benefit farmers, food processors, and consumers by providing higher-quality, more sustainable, and healthier food options. Arcadia Biosciences operates primarily in the United States, focusing on developing and commercializing its proprietary crop technologies. The company faces competition from other agricultural biotechnology companies and traditional seed companies.

What Products and Services Does RKDA Offer?

• Develop plant-based health and wellness products.
• Focus on crop improvement, primarily in wheat.
• Enhance farm economics through improved crop performance.
• Increase the value of crops as food ingredients.
• Improve the viability of crops for industrial applications.
• Utilize advanced breeding techniques and genetic engineering.

How Does RKDA Make Money?

• Develop proprietary crop technologies.
• License or sell improved crop varieties to farmers and seed companies.
• Generate revenue through sales of plant-based health and wellness products.
• Form strategic partnerships and collaborations to expand market reach.

What Industry Does RKDA Operate In?

Arcadia Biosciences operates in the agricultural inputs industry, which is characterized by increasing demand for sustainable and high-yield crop varieties. The industry is driven by factors such as population growth, climate change, and the need for more efficient agricultural practices. Key competitors include companies like CAPS, CNEY, ENFY, FMSTW, and GURE, which are also involved in agricultural biotechnology and crop improvement. The market is competitive, with larger players having significant resources for research and development and marketing. Arcadia Biosciences aims to differentiate itself through its focus on specific crop traits and its proprietary technologies.

Who Are RKDA's Key Customers?

• Farmers seeking to improve crop yields and reduce input costs.
• Food processors looking for higher-quality and more sustainable ingredients.
• Consumers interested in healthier and more nutritious food options.
• Seed companies that license or purchase Arcadia's improved crop varieties.

Company Profile

Arcadia Biosciences, Inc. operates in the Agricultural Inputs industry within the Basic Materials sector. It is headquartered in Davis, US. The company is led by CEO Thomas J. Schaefer. RKDA has traded publicly since 2015.

FY2026 estForward Outlook

Wall Street analysts project Arcadia Biosciences, Inc. revenue of about $7.7M for fiscal 2026, with EPS near $-2.42.

F-Score 2/9Financial Health

Arcadia Biosciences, Inc.'s Piotroski F-Score is 2/9, a 9-point checklist of profitability, leverage and efficiency — flagging fundamental weakness worth scrutiny.

RKDA Valuation & Market Position

With a $1.15M market cap, Arcadia Biosciences, Inc. sits in the micro-cap segment of the market. Relative to its peer group, RKDA's quantitative score of 16/100 is below the peer average of 55/100.

Net buyingInsider Activity

The most recent 12 insider filings for Arcadia Biosciences, Inc. break down as 0 sales and 12 purchases. On net that is roughly 146K shares acquired (about $426K) — insiders putting money in tends to read as conviction.

RKDA Financials

RKDA Latest News

RKDA Analyst Consensus

RKDA MoonshotScore

RKDA Basic Materials Stock FAQ

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Official Resources